Literature DB >> 16830246

[Symptom control and ethics in final stages of COPD].

Bernadette Hörfarter1, Dietmar Weixler.   

Abstract

On the basis of a case study, the complex problems of the final stages of a COPD will be demonstrated and discussed. Dyspnea and anxiousness are the primary symptoms. If they can be adequately brought under control by opiates and benzodiazepines, a palliative sedation is then not necessary. The communicative and ethical demands on the team responsible are high. It is important to be aware of the specific needs of the patient and of his/her family members, and to competently accompany the patient throughout the decision-making process--such as the decision to end respiratory therapy, for example. Clarifying the situation with the patient and finding out his/her wishes, accompanied by the corresponding documentation, is advisable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830246     DOI: 10.1007/s10354-006-0289-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  28 in total

1.  Sedation in terminally ill patients.

Authors:  J Hardy
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

2.  Predictors of outcome for patients with COPD requiring invasive mechanical ventilation.

Authors:  M L Nevins; S K Epstein
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

3.  Impact of ethics consultations in the intensive care setting: a randomized, controlled trial.

Authors:  L J Schneiderman; T Gilmer; H D Teetzel
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

Review 4.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

5.  Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  M T Claessens; J Lynn; Z Zhong; N A Desbiens; R S Phillips; A W Wu; F E Harrell; A F Connors
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

6.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.

Authors:  P K Plant; J L Owen; M W Elliott
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

7.  Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  M G Seneff; D P Wagner; R P Wagner; J E Zimmerman; W A Knaus
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

8.  Emotional burden of nurses in palliative sedation therapy.

Authors:  Tatsuya Morita; Mitsunori Miyashita; Rieko Kimura; Isamu Adachi; Yasuo Shima
Journal:  Palliat Med       Date:  2004-09       Impact factor: 4.762

9.  Dyspnea, anxiety, and depression in chronic respiratory impairment.

Authors:  R Kellner; J Samet; D Pathak
Journal:  Gen Hosp Psychiatry       Date:  1992-01       Impact factor: 3.238

Review 10.  Palliative care in the management of chronic obstructive pulmonary disease.

Authors:  Laura Blackler; Caroline Mooney; Christine Jones
Journal:  Br J Nurs       Date:  2004 May 13-26
View more
  4 in total

1.  [Palliative sedation therapy for severe dyspnoea].

Authors:  Walter Schippinger; Dietmar Weixler; Christof Müller-Busch
Journal:  Wien Med Wochenschr       Date:  2010-07

2.  [Invasive and non-invasive ventilation in conflict with best palliative care in severe COPD].

Authors:  Martin Mikesch; Peter Reichenpfader
Journal:  Wien Med Wochenschr       Date:  2009-12

3.  [Palliative sedation in pediatric oncology].

Authors:  Julia Kovacs; Nazar Casey; Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2008

Review 4.  Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

Authors:  Steffen T Simon; Irene J Higginson; Sara Booth; Richard Harding; Vera Weingärtner; Claudia Bausewein
Journal:  Cochrane Database Syst Rev       Date:  2016-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.